MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Recurrent Glioblastoma

  1. Home
  2. Diseases
  3. Recurrent Glioblastoma
  4. Clinical Trials

Clinical Trials Related to Recurrent Glioblastoma

Related studies linked through entity extraction aliases.

NCT00503204

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Status
COMPLETED
Phase
PHASE1

NCT00390299

Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Status
COMPLETED
Phase
PHASE1

NCT00250887

Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research

Status
COMPLETED
Phase
PHASE2

NCT00102648

Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.